Gyre Therapeutics announced the appointment of Rodney Nussbaum to the Company’s Board of Directors and as a member of its Audit Committee. Nussbaum currently serves as a Managing Executive at Atago Advisory
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
